Loading patent…
OwnerBertram Eichelinventor
Estimating the term…
The oral cavity is a source of sensitive biomarkers that allow the development of novel tobacco filters to reverse and eliminate acute adverse effects of tobacco smoke. Useful biomarkers are ubiquitous functional leukocytes and associated essential biochemical mechanisms, including metabolic pathways and specific enzymes, such as myeloperoxidase contained in fluid-cell lavages obtained from the human mouth. These biomarkers derived from the human mouth and sputum from the human respiratory system can be used to evaluate long-term chronic effects of tobacco smoke. A tobacco filter comprising strongly basic anion exchange resins and strongly acidic cation exchange resins with or without activated carbon, is used to detect, reduce and eliminate toxic substances from tobacco smoke while retaining taste and aroma. The novel filter in conjunction with biomarkers allow the establishment of performance standards that permit the direct visualization and measurement of acute adverse reactions caused by tobacco smoke. The measurement of these adverse effects allow a human health hazard reduction scale to be created to inform smokers of the relative “safety” of any smoking product.
A filter for tobacco products comprising:
A method of assessing the relative safety of tobacco products comprising the steps of:
A method of evaluating the adverse effects of tobacco products comprising the steps of:
The method of claim 39 further comprising the step of reducing the adverse effects of tobacco products to a value associated with a health hazard reduction scale.
A method of marketing tobacco products to consumers by labeling said tobacco products with a health hazard reduction scale, the method comprising the steps of:
A method of assessing the long term effects of chronic use of tobacco, comprising the steps of:
Dependencies are inferred from the claim text.